SEC
IOVA icon

Seven Eight Capital’s Iovance Biotherapeutics IOVA Stock Holding History

Seven Eight Capital’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-57,188
Closed -$537K – 298
2024
Q3 		$537K Sell
57,188
-20,052
-26% -$190K 0.05% 541
2024
Q2 		$619K Sell
77,240
-97,162
-56% -$1.04M 0.06% 474
2024
Q1 		$2.58M Buy
+174,402
New +$2.03M 0.27% 109
2023
Q4 		– Sell
-319,502
Closed -$1.45M – 723
2023
Q3 		$1.45M Buy
319,502
+187,253
+142% +$1.22M 0.17% 158
2023
Q2 		$931K Buy
132,249
+73,325
+124% +$525K 0.15% 190
2023
Q1 		$360K Sell
58,924
-151,476
-72% -$1.05M 0.08% 302
2022
Q4 		$1.34M Buy
210,400
+159,194
+311% +$1.24M 0.35% 86
2022
Q3 		$491K Sell
51,206
-54,574
-52% -$629K 0.1% 286
2022
Q2 		$1.17M Buy
105,780
+85,394
+419% +$1.12M 0.47% 54
2022
Q1 		$339K Buy
+20,386
New +$315K 0.05% 388
2021
Q4 		– Sell
-64,556
Closed -$1.59M – 571
2021
Q3 		$1.59M Buy
64,556
+600
+0.9% +$14.1K 0.15% 223
2021
Q2 		$1.66M Buy
+63,956
New +$1.66M 0.23% 136
2020
Q3 		– Sell
-9,397
Closed -$258K – 589
2020
Q2 		$258K Buy
+9,397
New +$309K 0.19% 218
2018
Q4 		– Sell
-27,600
Closed -$311K – 616
2018
Q3 		$311K Buy
+27,600
New +$392K 0.02% 510

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Seven Eight Capital's IOVA Position: Q4 2024 in Review

Seven Eight Capital sold out of Iovance Biotherapeutics (IOVA) in Q4 2024, closing a stake of 57,188 shares — an estimated $537K sold.

Seven Eight Capital first reported a position in IOVA in Q3 2018 and held it in 14 quarters. The position peaked at $2.58M in Q1 2024. 301 funds tracked by Wall St. Rank hold IOVA as of Q4 2024.

  • Seven Eight Capital reported no remaining Iovance Biotherapeutics position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 57,188 Iovance Biotherapeutics shares in Q4 2024, an estimated $537K.
  • Seven Eight Capital first reported a position in Iovance Biotherapeutics in Q3 2018 and held it in 14 quarters.
  • Seven Eight Capital's Iovance Biotherapeutics position peaked at $2.58M in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.